Recruiting

Radiology Training

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT04832698

Conditions

Malignant Vascular Neoplasm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

Survey Administration

Study Details

Brief summary:

This study looks at the comfort of interventional and diagnostic imaging residents in performing simulated endovascular procedures after completing training on the Mentice endovascular simulator device. Implementation of a training curriculum with radiology residents interested in interventional radiology will help facilitate hands-on training in a low-risk environment and allow for safer future patient encounters.

Conditions

Malignant Vascular Neoplasm

Study ID

NCT04832698

Start date

Jul 8, 2020

Status verified date

May, 2026

Completion date

Apr 30, 2028

Anticipated

Primary completion date

Apr 30, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

\- Current interventional and diagnostic radiology residents participating in the training curriculum on the Mentice Endovascular Simulator will be eligible to participate in the survey

Study Design

Enrollment

9 participants

Anticipated

Interventions and Outcome Measures

Arms

Observational (survey administration)

Participants complete a survey over 10 minutes before and after completing training and using the Mentice endovascular simulator device.

Interventions

Survey Administration

Complete survey

Primary outcome measure

  • Trainees' feelings about using simulation to help with procedural training [ Time Frame: through study completion, an average of 1 year ]

Central Contacts and Locations

Central contacts

Locations

M D Anderson Cancer Center

Recruiting

Houston, Texas, United States, 77030

Contacts

Principal Investigator:

Joshua D. Kuban

More Information

Sponsor

M.D. Anderson Cancer Center

Last update posted

Jun 2, 2026

Last verified

May, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2026-06-02.